John L. Lamattina, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 2,161 shares at $200.76 ($434K) on 2026-03-06, disclosed to the SEC on 2026-03-31.
Open-market sale of $434k LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LGND | SELL | 2024-12-02 | $595K | — | Filing → |
| LGND | SELL | 2021-11-17 | $1.6M | — | Filing → |
| IMNM | BUY | 2021-05-26 | $196K | — | Filing → |